Latest Stocks: Genpact Limited (G) Director James C. Madden Sells 5,224 Shares

Latest Stocks: Genpact Limited (G) Director James C. Madden Sells 5,224 Shares

Genpact Limited (NYSE:G) Director James C. Madden sold 5,224 shares of the business’s stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $25.51, for a total transaction of $133,264.24. Following the sale, the director now directly owns 8,970 shares in the company, valued at $228,824.70. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Genpact Limited (G) opened at 27.52 on Tuesday. Genpact Limited has a 12 month low of $22.58 and a 12 month high of $28.47. The firm has a market cap of $5.30 billion, a price-to-earnings ratio of 21.62 and a beta of 0.63. The firm’s 50 day moving average is $25.64 and its 200-day moving average is $24.62.

Genpact Limited (NYSE:G) last posted its earnings results on Thursday, May 4th. The business services provider reported $0.29 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.29. Genpact Limited had a net margin of 10.49% and a return on equity of 21.52%. The firm had revenue of $623 million during the quarter, compared to analyst estimates of $614.84 million. During the same period last year, the firm posted $0.31 earnings per share. Genpact Limited’s revenue for the quarter was up 2.2% compared to the same quarter last year. On average, equities analysts forecast that Genpact Limited will post $1.55 EPS for the current year.

A number of equities research analysts have recently issued reports on G shares. Zacks Investment Research raised shares of Genpact Limited from a “sell” rating to a “hold” rating in a report on Tuesday, February 28th. Jefferies Group LLC reaffirmed a “buy” rating on shares of Genpact Limited in a report on Friday, March 17th. BMO Capital Markets reiterated a “hold” rating and issued a $25.00 price target on shares of Genpact Limited in a research note on Thursday, March 23rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $27.00 price target on shares of Genpact Limited in a research note on Friday, February 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $28.38. Several hedge funds and other institutional investors have recently bought and sold shares of G. Fifth Third Bancorp raised its position in Genpact Limited by 1.2% in the first quarter. Fifth Third Bancorp now owns 9,976 shares of the business services provider’s stock worth $247,000 after buying an additional 121 shares during the period. Ngam Advisors L.P. raised its position in Genpact Limited by 0.6% in the first quarter. Ngam Advisors L.P. now owns 38,866 shares of the business services provider’s stock worth $962,000 after buying an additional 242 shares during the period. Genesee Valley Trust Co. raised its position in Genpact Limited by 3.0% in the first quarter. Genesee Valley Trust Co. now owns 13,947 shares of the business services provider’s stock worth $345,000 after buying an additional 405 shares during the period. Envestnet Asset Management Inc. raised its position in Genpact Limited by 3.0% in the first quarter. Envestnet Asset Management Inc. now owns 34,564 shares of the business services provider’s stock worth $855,000 after buying an additional 994 shares during the period. Finally, Bank of Montreal Can raised its position in Genpact Limited by 1.2% in the first quarter. Bank of Montreal Can now owns 117,378 shares of the business services provider’s stock worth $2,906,000 after buying an additional 1,379 shares during the period. 90.37% of the stock is owned by hedge funds and other institutional investors.

Receive News & Ratings for Genpact Limited Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Genpact Limited and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment